Quantifying Changes in Pain Sensitivity Using Reproducible Transcutaneous Optogenetic Stimulation in Behaving Mice
- 23 June 2026
- journal article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 46 (29)
Abstract
Optogenetics provides an unprecedented opportunity to delineate how different somatosensory afferents contribute to sensation, including pain. Afferents expressing channelrhodopsin-2 (ChR2) can be selectively activated by transcutaneous photostimuli applied to behaving mice. Despite targeting expression of ChR2 to specific cell types, imprecise photostimulation has hindered quantitative optogenetic-based behavioral testing. Here, we used a robot to reproducibly apply transcutaneous optogenetic stimuli to the hindpaw of mice while measuring nocifensive withdrawal. Different photostimulus waveforms (pulses and ramps) and response metrics (threshold and latency) were compared in mice of either sex expressing ChR2 in all afferents (Advillin-ChR2) or preferentially in nociceptors (Na V 1.8-ChR2). Inflammation induced by complete Freund’s adjuvant (CFA) caused withdrawal from ramped photostimuli to become faster relative to baseline and to vehicle-injected controls whereas pulsed photostimuli revealed a modest increase in threshold. Analgesia caused by Na V 1.7 and 1.8 channel blockade was evident in both testing protocols. Overall, ramp-based testing was more effective and more efficient (i.e., required less time and total stimulation) than pulse-based testing. Electrophysiological measurements confirmed that CFA increases nociceptor excitability without affecting phototransduction, suggesting that withdrawal latency depends on the number of nociceptors activated rather than how strongly each nociceptor is activated. Consistent with changes described in nociceptor somata, the behavioral consequences of peripherally blocking different voltage-gated sodium (Na V ) channels showed that nociceptor axons normally rely on Na V 1.8 but upregulate Na V 1.7 after CFA, with important clinical implications for drug efficacy. Collectively, these results demonstrate the utility of optogenetic pain testing when reproducibly delivered and strategically designed photostimuli are used.Keywords
Funding Information
- Canadian Institutes of Health Research (FDN167276)
This publication has 68 references indexed in Scilit:
- Comparison of Nocifensive Behavior in NaV1.7–, NaV1.8–, and NaV1.9–Channelrhodopsin‐2 Mice by Selective Optogenetic Activation of Targeted Sodium Channel Subtype‐Expressing AfferentsJournal of Neuroscience Research, 2024
- Compartment-specific regulation of NaV1.7 in sensory neurons after acute exposure to TNF-αCell Reports, 2024
- Reproducible and fully automated testing of nocifensive behavior in miceCell Reports Methods, 2023
- Cortical gamma-band resonance preferentially transmits coherent inputCell Reports, 2021
- Optogenetic exploration and modulation of pain processingExperimental Neurology, 2018
- Time-Resolved Fast Mammalian Behavior Reveals the Complexity of Protective Pain ResponsesCell Reports, 2017
- Afferent hyperexcitability in neuropathic pain and the inconvenient truth about its degeneracyCurrent Opinion in Neurobiology, 2016
- A field test of the directed deterrence hypothesis in two species of wild chiliOecologia, 2006
- Conditional gene deletion in primary nociceptive neurons of trigeminal ganglia and dorsal root gangliaGenesis, 2004
- Diversity of Expression of the Sensory Neuron-Specific TTX-Resistant Voltage-Gated Sodium Ion Channels SNS and SNS2Molecular and Cellular Neuroscience, 2000